Nathan Rice
Stock Analyst at Piper Sandler
(3.16)
# 1,082
Out of 5,182 analysts
61
Total ratings
52.63%
Success rate
12.22%
Average return
Main Sectors:
Stocks Rated by Nathan Rice
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BFC Bank First | Maintains: Neutral | $142 → $150 | $142.52 | +5.25% | 10 | Jan 26, 2026 | |
| FMBH First Mid Bancshares | Maintains: Overweight | $49 → $48 | $43.58 | +10.14% | 5 | Nov 3, 2025 | |
| MBIN Merchants Bancorp | Maintains: Overweight | $41 → $42 | $47.52 | -11.62% | 9 | Oct 30, 2025 | |
| BY Byline Bancorp | Maintains: Overweight | $34 → $35 | $33.34 | +4.98% | 9 | Oct 28, 2025 | |
| CVS CVS Health | Maintains: Buy | $85 → $74 | $77.62 | -4.66% | 2 | May 2, 2024 | |
| NIC Nicolet Bankshares | Assumes: Neutral | $84 | $158.42 | -46.98% | 1 | Jan 10, 2024 | |
| ALGN Align Technology | Downgrades: Sell | $197 | $184.69 | +6.67% | 10 | Dec 11, 2023 | |
| ELAN Elanco Animal Health | Maintains: Sell | $11 → $9 | $24.11 | -62.67% | 1 | Apr 25, 2023 | |
| IDXX IDEXX Laboratories | Upgrades: Buy | $530 → $435 | $584.05 | -25.52% | 4 | Jul 21, 2022 | |
| CI The Cigna Group | Initiates: Neutral | $233 | $272.60 | -14.53% | 5 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $83 | $37.26 | +122.76% | 4 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $15 | $21.61 | -30.59% | 1 | Dec 19, 2019 |
Bank First
Jan 26, 2026
Maintains: Neutral
Price Target: $142 → $150
Current: $142.52
Upside: +5.25%
First Mid Bancshares
Nov 3, 2025
Maintains: Overweight
Price Target: $49 → $48
Current: $43.58
Upside: +10.14%
Merchants Bancorp
Oct 30, 2025
Maintains: Overweight
Price Target: $41 → $42
Current: $47.52
Upside: -11.62%
Byline Bancorp
Oct 28, 2025
Maintains: Overweight
Price Target: $34 → $35
Current: $33.34
Upside: +4.98%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $85 → $74
Current: $77.62
Upside: -4.66%
Nicolet Bankshares
Jan 10, 2024
Assumes: Neutral
Price Target: $84
Current: $158.42
Upside: -46.98%
Align Technology
Dec 11, 2023
Downgrades: Sell
Price Target: $197
Current: $184.69
Upside: +6.67%
Elanco Animal Health
Apr 25, 2023
Maintains: Sell
Price Target: $11 → $9
Current: $24.11
Upside: -62.67%
IDEXX Laboratories
Jul 21, 2022
Upgrades: Buy
Price Target: $530 → $435
Current: $584.05
Upside: -25.52%
The Cigna Group
Dec 14, 2021
Initiates: Neutral
Price Target: $233
Current: $272.60
Upside: -14.53%
Dec 14, 2021
Initiates: Neutral
Price Target: $83
Current: $37.26
Upside: +122.76%
Dec 19, 2019
Initiates: Overweight
Price Target: $15
Current: $21.61
Upside: -30.59%